• No results found

Cardiac surgery and antiplatelet therapy


Academic year: 2021

Share "Cardiac surgery and antiplatelet therapy"


Full text


Göteborg, 2017


Cardiac surgery and antiplatelet therapy

Akademisk avhandling

Som för avläggande av medicine doktorsexamen vid Sahlgrenska akademin, Göteborgs universitet kommer att offentligen försvaras i Förmaket, Sahlgrenska Universitetssjukhuset,

Göteborg den 24 mars, klockan 9.00 av

Carl Johan Malm

Legitimerad Läkare Fakultetsopponent: Docent Jan Holst

Kärlkirurgiska kliniken, Skånes Universitetssjukhus

Avhandlingen baseras på följande delarbeten

I. Hansson EC, Malm CJ, Hesse C, Hornestam B, Dellborg M, Rexius H, Jeppsson A. Platelet function recovery after ticagrelor withdrawal in patients awaiting urgent coronary surgery. Eur J Cardiothor Surg, 2016; doi:10.1093/ejcts/ezw373.

II. Malm CJ, Hansson EC, Åkesson J, Andersson M, Hesse C, Shams Hakimi C, Jeppsson A. Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study. Br J Anaesth. 2016 Sep;117(3):309-15.

III. Malm CJ, Singh S, Hesse C, Jeppsson A. Aprotinin but not tranexamic acid improves in vitro platelet function in blood samples from ticagrelor and aspirin treated patients. Submitted.

IV. Malm CJ, Björklund E, Hansson EC, Wessman C, Rexius H, Nozohoor S, Nielsen S, Jeppsson A. Platelet inhibition and survival after coronary artery bypass grafting in patients with acute coronary syndrome: A nationwide study from the SWEDEHEART registry. Submitted.


Göteborg, 2017

ISBN: 978-91-629-0123-3 (TRYCK) ISBN: 978-91-629-0124-0 (PDF)


Cardiac surgery and antiplatelet therapy

Carl Johan Malm

Department of Molecular and Clinical Medicine, Insititute of Medicine Sahlgrenska Academy, University of Gothenburg, Sweden


Dual antiplatelet therapy (DAPT) with acetylsalicylic acid (ASA) and a P2Y12 inhibitor improves outcome in acute coronary syndrome (ACS). In the subset of ACS patients undergoing urgent cardiac surgery, ongoing or recently discontinued DAPT is associated with increased risk of bleeding. Postoperative DAPT in ACS patients after coronary artery bypass grafting (CABG) may improve graft patency and short-term survival. The aim of this project was to study ACS patients undergoing cardiac surgery and how DAPT with ASA and ticagrelor influences perioperative bleeding risks, how bleeding can be treated, and to investigate if survival after CABG is influenced by antiplatelet therapy.


In paper I, recovery of platelet function after discontinuation of ticagrelor was investigated using multiple-electrode aggregometry (MEA) in ACS patients awaiting CABG. The effect of platelet concentrate at different discontinuation times was also studied. Paper II was a

prospective observational study of patients undergoing cardiac surgery with ongoing or recently discontinued ticagrelor treatment. The relationship between preoperative MEA and

postoperative bleeding was investigated. In paper III, MEA was used to investigate the effect of aprotinin and tranexamic acid on platelet function in ACS patients with ongoing DAPT using ASA and ticagrelor. Paper IV was a nationwide study of all ACS patients undergoing isolated CABG surgery during a four-year period. The influence of postoperative antiplatelet therapy on one-year mortality was investigated using propensity score matching.


Mean platelet ADP-induced aggregation increased gradually after ticagrelor discontinuation and reached normal values after 72–96 hours. There was a large inter-individual variability. Platelet concentrate did not improve ADP-induced aggregation at any time, but markedly increased arachidonic acid-induced aggregation at all time points. Preoperative ADP-induced aggregation predicted severe bleeding complications, with an optimal cut-off of 22 aggregation units. Aprotinin, but not tranexamic acid increased ADP-induced aggregation in patients with ongoing DAPT using ASA and ticagrelor. Postoperative treatment with ASA + ticagrelor was associated with a reduced one-year mortality compared to ASA only (hazard ratio 0.42, p=0.020). Conclusions


Related documents

Användarna skall ges möjlighet till diskussion i ett diskussionsforum enbart för den specifika gruppen, få tillgång till viktiga dokument, kunna ändra respektive få nytt

Patients undergoing lung cancer surgery are often routinely treated by physiotherapists, but this treatment has not been thoroughly investigated, especially with regards to effect

• Patients who remained active or increased their level of physical activity two months after surgery had significantly better recovery of lung function compared to those

This thesis include one cohort study of physical activity and recovery of lung function in patients undergoing cardiac surgery, one validation study of two self-reported physical

Art-BG – arterial blood gas, DCC – Dipylon cardiac catheter, MD – microdialysis, P-glu – plasma glucose, POC – point-of-care analysis of capillary blood, SC-CGM –

Conclusions: Full-dose aprotinin reduces bleeding, transfusion requirements of packed red blood cells, platelets, and total number of blood units in patients on clopidogrel

A significant reduction of both postoperative bleeding volume and transfusion of allogenic blood products was observed in a study carried out on higher risk cardiac


II: Postoperative bleeding volume correlated univariately with preoperative fibrinogen concentration (r = -0.53, p<0.001). Fibrinogen was an independent predictor of

In turn, addition of SSP to incubation media resulted in a slight decrease in the total count of culturable microorganisms (Fig.2D). As shown in Fig.1, addition of inoculum to

Preoperative fibrinogen plasma concentration and factor XIII (FXIII) activity may be indicators of perioperative bleeding and transfusion. The aim of the thesis was to

Preoperative fibrinogen plasma concentration and factor XIII (FXIII) activity may be indicators of perioperative bleeding and transfusion. The aim of the thesis was to investigate

This was confirmed in paper II, showing that the preoperative ADP-induced platelet aggregation capacity predicted the risk of severe bleeding complications in cardiac

Key words: Kidney failure, acute; glomerular filtration rate; renal circulation; oxygen consumption; cardiac surgery; vasopressin; mannitol; levosimendan;

In contrast to dobutamine, levosimendan did not only increase cardiac output and renal blood flow, but also increased the glomerular filtration rate by 22%.

Aims: The aims were: to examine the preoperative levels of fibrinogen and other coagulation factors, and their relationship to postoperative bleeding and

More specifically, the im- portance of different coagulation factors for postoperative bleeding and transfu- sions was determined, the effects of a blood conservation

The general aim of this work was to investigate the effect of platelet inhibition on bleeding complications and transfusion requirements in cardiac surgery patients, to examine

Bleeding Complications in Cardiac Surgery Patients. Clinical and

BACKGROUND AND OBJECTIVE: Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y 12 inhibitor (clopidogrel, ticagrelor, or prasugrel) reduces thrombotic events

Tillväxtanalys har haft i uppdrag av rege- ringen att under år 2013 göra en fortsatt och fördjupad analys av följande index: Ekono- miskt frihetsindex (EFW), som

This work combines an image encoder, language encoder, relational network, and image generator to ground action words, and then visualize the effect an action would have on a

Förutom de bestämmelser i svensk lagstiftning om terroristbrott och brott med anknytning till terrorism som hittas i LST (2003:148) har ett antal andra lagar inflyttande